Delivery Order SPE2DB20D1109-SPE2DB23FP35D
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $22,538.46, is for the delivery of Eliquis 5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award, valued at $9,989.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. The contract is not designated as a set-aside and represents a portion of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $37,048.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has a period of performance through November 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $9,134.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets in 60-count packages. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of May 12, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $15,584.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and is a firm fixed-price delivery order with a completion date of June 25, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,184.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,044.40 firm fixed-price delivery order contract, which runs through December 31, 2024, is for the provision of Eliquis 5 mg tablets. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,989.32, is for the delivery of Eliquis 5 mg tablet (60 count) and has a completion date of May 16, 2024. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
- This federal contract award, valued at $10,073.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a prescription medication, over the period ending on April 17, 2025. This contract is not a set-aside and was awarded as a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $7,379.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP35DDelivery Order
This federal contract award, valued at $10,936.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablet (60 count) and has a completion date of June 20, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen's extensive experience in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems, makes them a key vendor for DLA contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 6/16/23 |